CONCEPTOMED AS
SalivaPOD™ - Saliva collection of DNA/RNA for PCR - ConceptoMed
Maximize flexibility and adaptability for Test-and-Trace operations. Utilize existing PCR diagnostic systems with highest sensitivity
Organization
- CEO
- CM
Christian Mide1971
- Chairman of the board
- BB
Bård Baldishol1968
- Years since formation
- 13 years
- since Mar 14, 2012
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 110,440
- 1 share class
- Total number of shareholders
- 2
- companies
- Belongs to group of
Financials
- Total operating income 2023
- 446,581
- NOK
- Annual total result 2023
- -4,592,640
- NOK
- Total equity 2023
- 9,643,957
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
CM 1971 | Managing Director/CEO | 13.35 % indirectly |
Board
| Name | Role | Shares |
|---|---|---|
BB 1968 | Chairman | 25.69 % indirectly |
LJ | Observer | - |
AL 1964 | Board Member | 25.69 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
BB 1968 | Chairman | 25.69 % indirectly |
AL 1964 | Board Member | 25.69 % indirectly |
CM 1971 | Managing Director/CEO | 13.35 % indirectly |
RN | - | 6.65 % indirectly |
KF | - | 2.51 % indirectly |
Last update: Mar 10, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 88,352 | 80 % | |
| Ordinary shares | 22,088 | 20 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2023: NOK 14,982,177Operating profit 2023: NOK -4,400,911Employees: 0
Financials
in NOK
Summary
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 446,581 | 0 | 14,122,320 |
Annual Total Result | -4,592,640 | -5,535,761 | 7,051,026 |
Total assets | 20,691,948 | 21,806,998 | 26,039,148 |
Total liabilities | 11,047,991 | 7,570,401 | 6,266,789 |
Total equity | 9,643,957 | 14,236,597 | 19,772,359 |
P&L
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 446,581 | 0 | 14,122,320 |
Total operating costs | 5,021,969 | 5,441,201 | 7,066,236 |
Operating result | -4,575,388 | -5,441,201 | 7,056,084 |
Financial income/costs | -17,252 | -94,561 | -5,058 |
Profit before tax | -4,592,640 | -5,535,761 | 7,051,026 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -4,592,640 | -5,535,761 | 7,051,026 |
Balance overview
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total fixed assets | 15,904,830 | 15,878,000 | 13,939,000 |
Total current assets | 4,787,118 | 5,928,998 | 12,100,148 |
Total assets | 20,691,948 | 21,806,998 | 26,039,148 |
Short term debt | 10,715,294 | 7,358,143 | 6,140,904 |
Long term debt | 332,697 | 212,258 | 125,885 |
Total liabilities | 11,047,991 | 7,570,401 | 6,266,789 |
Contributed capital | 9,643,957 | 12,721,333 | 12,721,333 |
Retained earnings | 0 | 1,515,265 | 7,051,026 |
Total equity | 9,643,957 | 14,236,597 | 19,772,359 |
Total equity and liabilities | 20,691,948 | 21,806,998 | 26,039,148 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises